Literature DB >> 25041437

Vitiligo nonsurgical treatment: a review of latest treatment researches.

Yanfei Zhang1, Jessini Soranambal Mooneyan-Ramchurn, Nan Zuo, Yiguo Feng, Shengxiang Xiao.   

Abstract

Vitiligo is a common depigmenting acquired disorder affecting about 1-2% of the world population, regardless of race, ethnic background, or gender. It is characterized by the appearance of milky white maculae because of a loss of melanocytes. The disfiguring nature of vitiligo causes high psychosocial morbidity. This is especially pronounced in populations with darker skin tone, likely because of the marked contrast. A variety of nonsurgical treatment regimens are currently employed in vitiligo. We reviewed the latest studies carried out on different nonsurgical treatment modalities used in vitiligo. All nonsurgical treatment aid to repigment or depigmentation the skin, however, many of them require a prolonged treatment course and may yield minimal results as well as carry unwanted side effects. There is a need for further research into the causes of vitiligo and into discovering better treatments.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  nonsurgical treatment; treatment; vitiligo

Mesh:

Substances:

Year:  2014        PMID: 25041437     DOI: 10.1111/dth.12143

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

1.  A New Therapy for Vitiligo Using Fire Needles: A Systematic Review of Evidence from 3618 Subjects.

Authors:  Ying Luo; Wei Qian; Ting Dai; Yi Ru; Xiaoying Sun; Le Kuai; Liu Liu; Meng Xing; Qi Zheng; Ying Zhang; Xi Chen; Huaibo Zhao; Bin Li; Xin Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-08-27       Impact factor: 2.629

2.  Design and Implementation of a Heating Treatment System for Vitiligo Skin Disease Based on Medical Ultrasound.

Authors:  Juanjuan Gao; Fei Tian; Chong Lyu; Xianhua Qiao
Journal:  J Healthc Eng       Date:  2021-03-09       Impact factor: 2.682

3.  The Evaluation of Vitiligous lesions Repigmentation after the Administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo (EVRAAS), a pilot study: study protocol for a randomized controlled trial.

Authors:  Anna Niezgoda; Andrzej Winnicki; Tomasz Kosmalski; Bogna Kowaliszyn; Jerzy Krysiński; Rafał Czajkowski
Journal:  Trials       Date:  2019-01-25       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.